CivicKnodeCivicKnowA project of CivicKnode
Sign in

SB 399

Did not advanceCrossfile HB 947
Add to calendar

Maryland Transit Administration - Disabled Reduced Fare Program for Opioid Treatment Program Patients - Modifications

Sponsor: Senator CarterCommittee: FinanceSubject: Transportation - GenerallyStatus: Hearing 2/03 at 1:00 p.m. (as of Dec 1, 2021)

What this bill does

Official synopsis

Altering requirements relating to participation in the Maryland Transit Administration's Disabled Reduced Fare Program by certain opioid treatment programs by requiring the Administration to allow opioid treatment programs to certify eligibility for and issue identification cards and monthly transit passes to qualifying patients; requiring rather than authorizing participating opioid treatment programs to issue the identification cards and transit passes to patients on-site; etc.

AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.

Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.

Testimony (8)

MGA witness list
FAV 7FavorableINFO 1Information only
PositionWitnessOrganizationTestimony
FAVAllen, EmilyMental Health Association of MarylandWritten (PDF)
FAVHarris, AlfredTurning Point ClinicOral
FAVAli, BilalIndividualOral
FAVBrocato, BarbaralobbyistIndividualWritten (PDF)
FAVCarter, JillIndividualOral + Written (PDF)
FAVSenator Carter, Senator CarterlegislatorIndividualOral
FAVSheahan, MollyIndividualWritten (PDF)
INFOWestervelt, PatriciaMaryland Department of TransportationWritten (PDF)

Organizations on record

Registered lobbyists who testified

FAVBrocato, BarbaraRegistered for: Acorn Health; American Physical Therapy Association Maryland - APTA MD; Arthritis & Rheumatism Associates, P.C.; Associates in Radiation Medicine; League for People with Disabilities, The; Maryland Academy of Nutrition and Dietetics